Literature DB >> 406865

Cardiac depression in bacteremia.

J Postel, P R Schloerb.   

Abstract

Hemodynamic and respiratory effects of a 5-hr IV infusion of Ps. aeruginosa at a dose of 10(8) organisms per ml per minute were studied in 6 dogs. Four dogs served as controls. Gramnegative bacteremia, with 70,000 +/- 1,800 organisms per ml of blood, caused a 50% reduction of cardiac output at three hrs. Peripheral vascular resistance increased significantly, but mean heart rate fell below control levels. Decline in mean systemic blood pressure from 150 +/- 5 mm Hg to 88 +/- 6 mm Hg was accompanied by a significant increase in pulmonary arterial wedge pressure with normal right atrial and pulmonary arterial pressures. Pulmonary vascular resistance also remained unchanged. With progression of the low output state and development of hypothermia, arteriovenous oxygen difference (A-V DO(2)) fell significantly. Despite a decline in functional residual capacity, venoarterial admixture diminished in the face of reduced pulmonary capillary perfusion, normal arterial Po(2) values, decline in body temperature and finally very narrow A-V DO(2). Histologically, ventricular myocardium revealed severe interstitial edema. It is concluded that myocardial dysfunction may occur early during gramnegative bacteremia, and formation of myocardial edema appears to be a significant contributing factor in myocardial failure.

Entities:  

Mesh:

Year:  1977        PMID: 406865      PMCID: PMC1396193          DOI: 10.1097/00000658-197707000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

1.  Experimental endotoxin shock. Circulatory changes with emphasis upon cardiac function.

Authors:  F ALICAN; M L DALTON; J D HARDY
Journal:  Am J Surg       Date:  1962-06       Impact factor: 2.565

2.  Physical factors affecting normal and serotonin-constricted pulmonary vessels.

Authors:  A M RUDOLPH; P A AULD
Journal:  Am J Physiol       Date:  1960-04

3.  Influence of pulmonary arterial and left atrial pressures on pulmonary vascular resistance.

Authors:  H G BORST; M MCGREGOR; J L WHITTENBERGER; E BERGLUND
Journal:  Circ Res       Date:  1956-07       Impact factor: 17.367

4.  Distribution of ventalation and perfusion in the lobes of the dog's lung in the supine and erect position.

Authors:  H RAHN; P SADOUL; L E FARHI; J SHAPIRO
Journal:  J Appl Physiol       Date:  1956-01       Impact factor: 3.531

5.  Cardiopulmonary effects of volume loading of primates in endotoxin shock.

Authors:  L J Greenfield; R H Jackson; R C Elkins; J J Coalson; L B Hinshaw
Journal:  Surgery       Date:  1974-10       Impact factor: 3.982

6.  Myocardial function in shock.

Authors:  L B Hinshaw; L T Archer; M R Black; R C Elkins; P P Brown; L J Greenfield
Journal:  Am J Physiol       Date:  1974-02

7.  Comparison of canine responses to Escherichia coli organisms and endotoxin.

Authors:  L B Hinshaw; L A Solomon; D D Holmes; L J Greenfield
Journal:  Surg Gynecol Obstet       Date:  1968-11

8.  Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock.

Authors:  J H Siegel; M Greenspan; L R Del Guercio
Journal:  Ann Surg       Date:  1967-04       Impact factor: 12.969

9.  Nomograms for correction of blood Po2, Pco2, pH, and base excess for time and temperature.

Authors:  G R Kelman; J F Nunn
Journal:  J Appl Physiol       Date:  1966-09       Impact factor: 3.531

10.  Pathophysiologic alterations during bacterial infusions for the study of bacteremic shock.

Authors:  J Postel; P R Schloerb; D Furtado
Journal:  Surg Gynecol Obstet       Date:  1975-11
View more
  2 in total

1.  Septic shock: a heart story since the 1960s.

Authors:  C Rabuel; A Mebazaa
Journal:  Intensive Care Med       Date:  2006-03-29       Impact factor: 17.440

Review 2.  Molecular events in the cardiomyopathy of sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Markus S Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.